Vet World   Vol.18   December-2025  Article - 26 

Immunogenicity and protective efficacy of a native omp34 subunit vaccine against Aeromonas hydrophila in BALB/c mice: Identification of nitroblue tetrazolium as a correlate of protection within a One Health framework

Rozi Rozi^1,2 , Wiwiek Tyasningsih³ , Jola Rahmahani³ , Eduardus Bimo Aksono Herupradoto⁴ , Muchammad Yunus⁵ , Mohammad Anam Al Arif⁶ , Suryo Kuncorojakti⁷ , Annas Salleh⁸ , and Suwarno Suwarno³

Background and Aim: Aeromonas hydrophila is a zoonotic, antimicrobial-resistant pathogen that causes significant losses in aquaculture and raises important One Health concerns. Outer membrane protein (OMP)–based subunit vaccines provide a targeted, antibiotic-sparing alternative to traditional bacterins, but validation across mammalian species remains limited. This study assessed the immunogenicity, safety, and protective effectiveness of a native ~34 kDa Omp34 (nOmp34) subunit vaccine in BALB/c mice, comparing it to a formalin-killed cell (FKC) vaccine, and examined immune factors that may predict survival. 

Materials and Methods: Female BALB/c mice (n = 13 per group) received subcutaneous injections of phosphate-buffered saline (PBS), FKC, FKC + incomplete Freund’s adjuvant (IFA), or native Omp34 + IFA on days 0, 14, and 28. Immune responses were assessed by measuring anti-Omp34 immunoglobulin (Ig)G2a levels via enzyme-linked immunosorbent assay, serum lysozyme activity, nitroblue tetrazolium (NBT) respiratory burst, and phagocytic activity at specified intervals up to day 42. On day 42, mice were challenged intraperitoneally with a lethal dose of A. hydrophila, causing 80% mortality, and observed for 14 days for survival, clinical scores, and body weight changes. Data analysis involved analysis of variance with Tukey post hoc tests, mixed-effects modeling, Spearman correlation, receiver operating characteristic curves, logistic regression, and Kaplan–Meier survival analysis. 

Results: By day 42, all immune biomarkers showed clear separation (nOmp34+IFA > FKC + IFA > PBS; p < 0.05). NBT demonstrated the strongest correlation with survival (ρ ≈ 0.90) and the highest predictive performance (Area under the curve [AUC] ≈ 0.80), exceeding IgG2a and phagocytosis (AUC ≈ 0.70). Post-challenge survival rates were 84.6% for nOmp34 + IFA, 61.5% for FKC + IFA, and 23.1% for PBS, corresponding to relative percent survival values of 80% and 50% compared to PBS. The direct comparison between nOmp34 and FKC revealed a favorable but not statistically significant survival benefit (p = 0.238). Vaccination was well-tolerated, with stable body weight, minimal reactogenicity, and no severe clinical events. 

Conclusion: The nOmp34 subunit vaccine elicited a strong, coordinated humoral and innate immune response, surpassing the matched bacterin in both efficacy and immune strength. NBT activity between days 35–42 proved to be a practical indicator of protection, aligning mechanistically with nicotinamide adenine dinucleotide phosphate -oxidase–mediated bacterial killing. These findings offer proof-of-concept for Omp34 as a scalable, antibiotic-sparing vaccine candidate and support its progression into aquaculture-relevant platforms within a One Health framework. 

Keywords: Aeromonas hydrophila, nOmp34 subunit vaccine, IgG2a enzyme-linked immunosorbent assay, reactive oxygen species, phagocytic activity, protective efficacy, Life below water.

How to cite this article: Rozi R, Tyasningsih W, Rahmahani J, Aksono Herupradoto EB, Yunus M, Anam Al Arif M, Kuncorojakti S, Salleh A, and Suwarno S (2025) Immunogenicity and protective efficacy of a native omp34 subunit vaccine against Aeromonas hydrophila in BALB/c mice: Identification of nitroblue tetrazolium as a correlate of protection within a One Health framework, Veterinary World, 18(12): 4025–4045.

Received: 28-08-2025   Accepted: 21-11-2025   Published online: 23-12-2025

Corresponding author: Suwarno Suwarno    E-mail: suwarno@fkh.unair.ac.id

DOI: 10.14202/vetworld.2025.4025-4045

Copyright: Rozi, et al. This article is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.